CLINICAL_TRIALS
trial_result
· 2019-03-01
Clinical Trial Update: A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056) [Phase 1]
Summary
Phase 1 trial update for ridaforolimus (MK-8669) in pediatric participants with advanced solid tumors; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2019-03-01